Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Aaron James Scott

Role not yet determined Is this you? Add your title

Also affiliated: Northwell Health (2025); Ministry of Health (2021); St George's Hospital (2003); American Society of Clinical Oncology (2025); University of Arizona (2017–2026); The University of Melbourne (2021); St George's, University of London (2003); University of Massachusetts Chan Medical School (2025); Austin Hospital (2021); BioSciCon (United States) (2020); Banner - University Medical Center Tucson (2017–2022); University of Colorado Cancer Center (2011–2016); Wellcome Library (1998); Olivia Newton-John Cancer Wellness & Research Centre (2021); Arizona Oncology (2017–2026); NRG Oncology (2023); University of Arizona Cancer Center (2017–2026); Hacettepe University (2021); University of Birmingham (2025–2026); University of Colorado Denver (2011–2016)

27 h-index 232 pubs 3,527 cited

  • Humans
  • Female
  • Male
  • Adult
  • Middle Aged
  • Aged
  • Colorectal Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • COVID-19
  • Diabetes Mellitus, Type 2
  • United States
  • COVID-19 Vaccines
  • Adenocarcinoma
  • Animals
  • Vaccination Hesitancy

Biography and Research Information

OverviewAI-generated summary

Aaron James Scott's research has explored various aspects of cancer treatment and patient outcomes, with a particular focus on gastrointestinal malignancies. His work includes investigating the application of circulating tumor DNA (ctDNA) in colorectal cancer, as detailed in a whitepaper for the NCI Colon and Rectal–Anal Task Forces. He has also contributed to studies on novel therapeutic agents, such as zanidatamab for biliary tract cancer and rigosertib for pancreatic cancer.

Scott's research also extends to the immunological aspects of cancer treatment and patient health. He has been involved in studies examining immune responses to vaccinations in adults with solid tumors and the development of immunochemotherapy using nanovesicles. His work has also touched upon broader public health topics, including the impact of influenza-like illnesses on productivity and healthcare utilization.

With a significant publication record (232 publications) and an h-index of 27, Scott has collaborated extensively with colleagues at the University of Arkansas for Medical Sciences, including Brett Rowland, James P. Selig, Jennifer A. Andersen, and Don E. Willis.

Metrics

  • h-index: 27
  • Publications: 232
  • Citations: 3,527

Selected Publications

  • Co-developing implementation strategies to support STEADI (Stopping Elderly Accidents, Deaths, and Injuries) for older adult fall prevention in outpatient physical therapy (2026)
  • Implementing STEADI for routine falls prevention of all older adults attending outpatient physical therapy: key partner perspectives (2026)
    Frontiers in Health Services 1 citation DOI OpenAlex
  • Increasing trainee engagement with autism evaluation and diagnosis: a quality improvement project (2026)
  • Correction: Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans (2025)
    Journal of General Internal Medicine DOI OpenAlex
  • Determinants of Implementing an Adapted Version of STEADI for Fall Prevention of Older Adults Attending Outpatient Rehabilitation in a Large Health Care System (2025)
    Journal of Geriatric Physical Therapy 3 citations DOI OpenAlex
  • Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents (2025)
    Clinical and Translational Science 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

74 Collaborators 21 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics